Investigating the Cellular Targets of HIV Protease Inhibitors: Implications for Metabolic Disorders and Improvements in Drug Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1875-5852|2|1|1-8

ISSN： 1568-0053

Source： Current Drug Targets - Infectious Disorders, Vol.2, Iss.1, 2002-03, pp. : 1-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug Interactions of HIV Protease Inhibitors

By Malaty L.I.  

Drug Safety, Vol. 20, Iss. 2, 1999-02 ,pp. : 147-169

Adis International

Access to resources Recommend Favorite

Metabolic Complications Associated with HIV Protease Inhibitor Therapy

By Nolan D.  

Drugs, Vol. 63, Iss. 23, 2003-01 ,pp. : 2555-2574

Adis International

Access to resources Recommend Favorite

The Cellular Pharmacokinetics of HIV Protease Inhibitors: Current Knowledge and Future Perspectives

By  

Current Drug Metabolism, Vol. 13, Iss. 8, 2012-10 ,pp. : 1174-1183

Bentham Science Publishers

Access to resources Recommend Favorite

Drug Interactions between HIV Protease Inhibitors and Acid-Reducing Agents

By Falcon Ronald W.  

Clinical Pharmacokinetics, Vol. 47, Iss. 2, 2008-01 ,pp. : 75-89

Adis International

Access to resources Recommend Favorite

Prospects for the Resistance to HIV Protease Inhibitors: Current Drug Design Approaches and Perspectives

By  

Current Pharmaceutical Design, Vol. 11, Iss. 24, 2005-01 ,pp. : 3077-3090

Bentham Science Publishers

Access to resources Recommend Favorite